CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease ; volume:14 ; number:1 ; day:29 ; month:12 ; year:2022 ; pages:1-10 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (29.12.2022), 1-10, 12.2022
- Creator
-
Lerner, Alan J.
Arnold, Steven E.
Maxfield, Erin
Koenig, Aaron
Toth, Maria E.
Fortin, Brooke
Mast, Natalia
Trombetta, Bianca A.
Denker, John
Pieper, Andrew A.
Tatsuoka, Curtis
Raghupathy, Sangeetha
Pikuleva, Irina A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-022-01151-z
- URN
-
urn:nbn:de:101:1-2023031021044298425820
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lerner, Alan J.
- Arnold, Steven E.
- Maxfield, Erin
- Koenig, Aaron
- Toth, Maria E.
- Fortin, Brooke
- Mast, Natalia
- Trombetta, Bianca A.
- Denker, John
- Pieper, Andrew A.
- Tatsuoka, Curtis
- Raghupathy, Sangeetha
- Pikuleva, Irina A.
- SpringerLink (Online service)
Other Objects (12)
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer’s disease early phenotypes
Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease
Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models
Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer’s astrocytes
Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation
Alzheimer’s Disease
A Novel Contrast Agent Based on Magnetic Nanoparticles for Cholesterol Detection as Alzheimer’s Disease Biomarker
Analysis of the protein network of cholesterol homeostasis maintenance in a mouse model of Alzheimer’s disease
Alzheimer
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer’s disease early phenotypes
Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease
Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models
Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer’s astrocytes
Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation
Alzheimer’s Disease
A Novel Contrast Agent Based on Magnetic Nanoparticles for Cholesterol Detection as Alzheimer’s Disease Biomarker
Analysis of the protein network of cholesterol homeostasis maintenance in a mouse model of Alzheimer’s disease
Alzheimer
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer’s disease early phenotypes
Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease
Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models
Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer’s astrocytes
Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation
Alzheimer’s Disease
A Novel Contrast Agent Based on Magnetic Nanoparticles for Cholesterol Detection as Alzheimer’s Disease Biomarker
Analysis of the protein network of cholesterol homeostasis maintenance in a mouse model of Alzheimer’s disease